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The aims of the present study were to validate the Norwegian translated Muscle Dysmorphic Disorder 
Inventory (MDDI) and explore the presence of muscle dysmorphia (MD) symptomatology in Norwegian 
gym-going men. A secondary aim was to examine differences in MD symptomatology and weekly training 
duration (WTD) according to the participants’ body mass index (BMI), and further investigate relationships 
between all measured variables. Participants (N = 124; Mage = 24.8, SD = 6.7 years) completed the translated 
MDDI, and according to BMI, 65 participants were of normal weight and 59 were overweight. A good fit 
from the confirmatory factor analysis, the results from the construct validity from the principal components 
analysis, and the detected good internal consistency indicate that the Norwegian translated MDDI is a valid 
and reliable measure for MD symptomatology. Moreover, MD symptomatology was present with mean 
scores of 33.7 (SD = 6.6), 15.2 (SD = 3.9), 10.4 (SD = 3.5), and 8.1 (SD = 2.6) for the MDDI total, and for the 
subscales: drive for size (DFS), functional impairment (FI), and appearance intolerance (AI), respectively. 
Statistical significant differences were detected between the normal weight and overweight participants 
in DFS, AI, FI (d≤.4, p<.01) and in WTD (d=.7, p<.01), but not significant for the MDDI total score (d=.1, 
p>.05). Lastly, WTD had a statistically significant correlation with FI and BMI (p<.01), whereas BMI had 
a statistical significant correlation with DFS, FI, and AI (p<.05). In conclusion, the translated Norwegian 
MDDI was found to be valid, but additional validations are needed with larger sample sizes. The presence of 
MD symptomatology and WTD was higher in the overweight compared to the normal weight participants. 
The findings further suggest that the subscale scores might better assist practitioners in evaluating MD 
concerns and offer appropriate care, as a MDDI cut-off score have yet to be validated. 
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Introduction
Muscle dysmorphia (MD) is a condition in 
which individuals (predominantly men) focus on 
muscularity and hold a pathological belief of not 
being muscular enough (Choi, Pope, & Olivardia, 
2002; Pope, Gruber, Choi, Olivardia, & Phillips, 
1997; Pope, et al., 2005; Pope, Katz, & Hudson, 
1993). Despite the observed disagreement in the 
literature around the diagnostic classification 
of MD amongst researchers (Dos Santos Filho, 
Tirico, Stefano, Touyz, & Claudino, 2016; Maida 
& Armstrong, 2005; Murray, et al., 2012; Murray, 
Rieger, Touyz, & De la Garza Garcia Lic, 2010; 
Nieuwoudt, Zhou, Coutts, & Booker, 2012), MD 
is currently recognized as a specifier for the body 
dysmorphic disorder in the Diagnostic and Statistical 
Manual of Mental Disorders, Fifth Edition (Amer-
ican Psychiatric Association, 2013). In recent years, 
Tod, Edwards, and Cranswick (2016) suggested 
that MD had sparked a global interest among 
researchers providing evidence of the presence of 
MD symptomatology across different cultures. This 
global interest will enable cross-cultural compar-
ison research and might add further understanding 
to the societal role in MD development and preva-
lence (Sandgren & Lavallee, 2018; Tod, et al., 2016). 
Absence of MD research in the Scandinavian popu-
lation compared to other European populations are 
notably observed, and particularly in the Norwegian 
population. Previous research from Scandinavia, 
however, have investigated symptoms of eating 
disorders and body dissatisfaction in adolescent 
boys and girls (Bratland-Sanda & Sundgot-Borgen, 
2012; Børresen & Rosenvinge, 2003; Kjelsås, 
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Bjørnstrøm, & Götestam, 2004). Higher scores of 
drives for muscularity in boys compared to girls 
were found in the Norwegian sample (Bratland-
Sanda & Sundgot-Borgen, 2012), indicating that it 
is possible that symptoms of MD are present in the 
Norwegian population. However, more research is 
needed to understand the presence of MD in Norwe-
gian samples. 
Earlier research has outlined the characteristics 
of MD, such as appearance checking (e.g., constant 
mirror checking), extreme dieting, high levels of 
anxiety and stress, impaired functioning, and 
spending a significant amount of time training to 
increase levels of muscularity due to feeling dissat-
isfied with the current level of muscularity (Blouin 
& Goldfield, 1995; Leone, Sedory, & Gray, 2005; 
Mosley, 2009). Guidi, Clementi, and Grandi (2013) 
reported that the participants with a high addic-
tion to exercise scored higher on MD symptoms 
and related psychopathology (i.e., patterns of disor-
dered eating) compared to the control participants, 
and Soler, Fernandes, Damasceno, and Novaes 
(2013) suggested that higher scores of MD symp-
tomatology was correlated with a higher exercise 
dependency in 151 male gym-goers and 25 male 
bodybuilders.
Indeed, men with current MD, and men with a 
history of MD reveal notably greater levels of body 
dissatisfaction compared to men with no history 
of MD (Cafri, Olivardia, & Thompson, 2008). 
Research has shown that the drive and desire for 
muscle size, and behaviors indicating functional 
impairment (e.g., arranging one’s schedule around 
training and dieting regimen) may predict MD in 
physically active men and women (Robert, Munroe-
Chandler, & Gammage, 2009). In addition to the 
drive and desire for muscle size, these individuals 
also desire greater muscle leanness and definition 
(e.g., having large muscles in the absence of body 
fat; Cafri, Blevins, & Thompson, 2006). The risk 
of using anabolic androgenic steroids to achieve 
larger muscles have also been associated with MD 
(González-Martí, Fernández-Bustos, Contreras, & 
Sokolova, 2017; Segura-Garcia, et al., 2010). Hilde-
brandt, Schlundt, Langenbucher, and Chung (2006) 
aimed to evaluate different types of body image 
disturbance among male weightlifters, and revealed 
five different types of respondents: dysmorphic, 
muscle concerned, fat concerned, normal behav-
ioral, and normal. The dysmorphic and muscle 
concerned groups reported higher levels of body 
image disturbances, related psychopathology, 
steroid abuse, and appearance-checking behaviors 
consistent with MD symptomatology compared to 
the other groups.
The body mass index (BMI) is an anthropo-
metric measure commonly used for estimating the 
body size (under-/normal/overweight) in individuals 
and is often used to describe physical characteris-
tics in research participants. Early research noted 
a lack of support for the relationship between BMI 
and MD symptomatology (Cafri, et al., 2005), and 
Grieve (2007) suggested body mass was a risk factor 
for MD, but stated the relationship needed further 
evaluation. Others have reported that body dissat-
isfaction in college men was stronger associated 
with overweight BMI’s compared to normal weight 
or underweight BMI’s (e.g., Watkins, Christie, & 
Chally, 2008); and in a recent study of 141 weight 
training males classified according to their BMI and 
somatotype, 17 of 68 normal weight, 22 of 66 over-
weight, and 6 of 7 obese participants were classi-
fied with potential cases of MD (Martinez Segura, 
Rizo Baeza, Sánchez Ferrer, Reig Garcia-Galbis, & 
Cortes Castell, 2014). Murray et al. (2012) measured 
the BMI of 21 men with MD, 24 men with anorexia 
nervosa and a control group of 15 gym-going men; 
the BMI was statistically significantly higher in 
the MD group compared to the other groups. The 
absence of reporting lean muscle mass and fat 
mass combined with the number of obese partici-
pants in Martinez et al. (2014) limits inference of 
MD being associated with obesity, and Murray et 
al. (2012) only reported the participants’ BMI for 
descriptive purposes, which further limits infer-
ence of the relationship between BMI and MD. Tod 
et al. (2016) suggested examining physical charac-
teristics with social and psychological variables, 
rather than treating them as individual predictors, 
which might add to a greater understanding. Hence, 
further examination of BMI’s relationship with MD 
symptomatology, and with other variables such as 
training duration, could advance knowledge of such 
relationships. 
With regard to the prevalence of MD, estimates 
have been proposed, although generalizable figures 
are lacking. The reported estimates include 13.6% 
prevalence of MD in 88 weight-training men using 
the Graduate Hannover Scale (Behar & Molinari, 
2010), 110 of 648 (17%) male weightlifters at risk 
of developing MD using the Muscle Appearance 
Satisfaction Scale, and 60 (9.3%) at risk of devel-
oping both MD and eating disorders (Nieuwoudt, 
Zhou, Coutts, & Booker, 2015). Furthermore, 45 
out of 141 (31.9%) gym-going men were classi-
fied with MD when given the Muscle Appearance 
Satisfaction Scale (Martinez Segura, Cortes Castell, 
Rizo Baeza, & Gil Guillen, 2015), and significantly 
severe MD symptoms were reported in 33 of 472 
(6.9%) young male students using the Drive for 
Muscularity Scale (Compte, Sepulveda, & Torrente, 
2015). The variations observed in prevalence are 
likely due to the various instruments used and 
employing measurements that do not measure all 
features associated with MD (e.g., Drive for Muscu-
larity Scale and Graduate Hannover Scale; Suffolk, 
Dovey, Goodwin, & Meyer, 2013). However, a 
widely used measurement for the assessment of 
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MD symptomatology is the Muscle Dysmorphic 
Disorder Inventory (MDDI; Hildebrandt, Langen-
bucher, & Schlundt, 2004). To date, the MDDI is 
considered to target MD as a disorder, and has iden-
tified MD symptomatology across various study 
samples, including: gym-goers (Soler, et al., 2013), 
competitive and non-competitive bodybuilders 
(Fabris, Longobardi, Prino, & Settanni, 2017; 
Longobardi, Prino, Fabris, & Settanni, 2017), male 
anabolic steroids users (Murray, Griffiths, Mond, 
Kean, & Blashill, 2016), university students (Bo, et 
al., 2014), and patients with MD (Murray, Rieger, 
Karlov, & Touyz, 2013). 
Therefore, to be able to establish a Norwegian 
sample norm and allow for future cross-cultural 
comparisons, the primary purpose of the present 
study was (a) to provide a further validation of the 
MDDI, and (b) to explore the presence of MD symp-
tomatology in Norwegian gym-going men. The 
secondary purpose of this study was to examine 
differences in MD symptomatology according to 
participants’ BMI, and further investigate the rela-
tionships between MD symptomatology, BMI, and 
weekly training duration (WTD). 
Methods
Participants
The participants were recruited from five gyms 
in the region of Stavanger, Norway, and consisted 
of 124 Norwegian gym-going men, with a self-
reported Mage = 24.8, SD = 6.7 years; Mweight = 83.6, 
SD = 13.6 kg; Mheight = 181.2, SD = 6.6 cm, and MWTD 
= 6.9, SD = 3.7 hours. Furthermore, 35.5% of partici-
pants were students, 39.5% were full- or part-time 
employed, 22.6% were both employed and students, 
and 2.4% were neither employed nor students at the 
time of participation. Participants had to be 18 years 
or older with an active gym-membership of at least 
six months to be included in the current study. They 
were further classified into two groups according 
to the World Health Organization (2000) adult clas-
sification for BMI (normal weight: 18.5–24.9 kg/
m2, and overweight: >25 kg/m2). Sixty-five partici-
pants (52.4%; MBMI = 23.0, SD = 1.6) were of normal 
weight (Mage = 23.9, SD = 5.8 years; Mweight = 74.8, 
SD = 7.5 kg; Mheight = 180.3, SD = 6.1 cm; MWTD = 
5.9, SD = 2.8 hours), and 59 (47.6%; MBMI = 28.1, 
SD = 3.2) were overweight (Mage = 25.9, SD = 1.0 
years; Mweight = 93.3, SD = 12.2 kg; Mheight = 182.2, 
SD = 7.1 cm; MWTD= 8.0, SD = 4.3 hours). The study 
was conducted in line with the ethical guidelines at 
the University of Stavanger, and written informed 
consent was obtained from every participant. 
Measurement
Participants completed the MDDI developed 
by Hildebrandt et al. (2004) to examine MD symp-
tomatology. In the present study, the MDDI was 
translated from its original language (English) to 
Norwegian, and the validity and reliability of the 
translated MDDI was assessed using three steps: 
(1) face validity was tested by having language 
experts conducting the translation and then present 
the translated questionnaire to researchers who 
understand the topic to carefully read the question-
naire; (2) data were collected; and (3) a confirma-
tory factor analysis (CFA), and the principal compo-
nents analysis (PCA) approach was carried out.
Instrument
The MDDI is grounded in previously published 
MD diagnostic criteria (Pope, et al., 1997), and 
consists of 13 self-report statements in three 
subscales pertaining to main MD symptomatology: 
drive for size (DFS), appearance intolerance (AI), 
and functional impairment (FI). The DFS subscale 
consists of statements pertaining to drive for larger 
muscles, and thoughts of being less muscular 
than desired. The AI subscale consists of state-
ments regarding negative beliefs about one’s body, 
resulting in body exposure avoidance and appear-
ance anxiety. The FI subscale consists of statements 
pertaining to training-behavior patterns, avoid-
ance of social or occupational situations because 
of negative feelings and a preoccupation with one’s 
body, and stress and anxiety when deviating from 
exercise routines (Hildebrandt, et al., 2004). The 
MDDI English and Italian versions have demon-
strated good test-retest reliability, internal consist-
ency, and convergent and divergent validity (Hilde-
brandt, et al., 2004; Santarnecchi & Dettore, 2012). 
Procedure
Data collection was performed in the gyms’ 
reception areas where the lead researcher 
approached and recruited the participants. Partici-
pants were given details about the study and the 
procedure of participation. Those who agreed to 
participate in the study first signed consent, there-
after provided demographic information, and lastly 
completed the Norwegian MDDI.
Statistical analysis
Raw data were transferred to IBM SPSS statis-
tics version 25 for further analysis. To examine the 
construct validity of the MDDI, PCA was applied. 
To examine if the PCA would produce a reliable 
result from the translated MDDI, the sampling 
adequacy and the suitability of the data reduc-
tion was examined using the Kaiser-Meyer-Olkin 
(KMO) and Bartlett’s test of sphericity (Tavakol & 
Dennick, 2011). The KMO measure of sampling 
adequacy ranges from 0 to 1, and the accepted 
index was set to >.6; and the significance level for 
acceptance of the Bartlett’s test of sphericity was 
set to p<.05. The PCA were performed using corre-
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lation matrix with the extraction method based on 
the eigenvalue greater than 1 and with the direct 
oblimin rotation method. Small coefficients below 
.30 were suppressed and not considered in the anal-
ysis. Furthermore, the CFA was executed using 
IBM SPSS Amos version 25, where a model was 
developed, and the CFA was evaluated by calcu-
lating chi-square, incremental fit index (IFI), 
Tucker-Lewis index (TLI), Comparative fit index 
(CFI), and root mean square error of approxima-
tion (RMSEA). Values closer to 1 and above .9 for 
the IFI, TLI (Bollen, 1989) and CFI (Bentler, 1990) 
would be considered as a good fit. Furthermore, a 
RMSEA value of about .05 or less would indicate 
a close fit of the model in relation to the degrees 
of freedom. However, a value of about .08 or less 
for the RMSEA would indicate a reasonable error 
of approximation (Browne & Cudeck, 1993). The 
minimum discrepancy (CMIN) and the degree of 
freedom for the CMIN (CMIN/DF) have also been 
reported as an indication of the overall model fit, 
and a degree of freedom between 1 and 3 was set 
as an indicative of an acceptable fit between the 
hypothetical model and the sample data (Carmines 
& McIver, 1981). 
The internal consistency was measured using 
Cronbach’s α, which ranges from 0 to 1 where 
α>.9 = excellent; α>.8 = good; α>.7 = acceptable; 
α>.6 = questionable; α>.5 = poor; and α<.5 = unac-
ceptable (George & Mallery, 2003). Furthermore, 
the normality of the data was examined using the 
Shapiro-Wilk and Kolmogorov-Smirnov tests, and 
results revealed that the variables were not normally 
distributed. Therefore, chi-square and nonpara-
metric Kruskal-Wallis tests were performed to 
examine differences in MDDI total and subscale 
scores and WTD between the normal weight and 
overweight participants. To determine the size of 
these differences, effect sizes (Cohen’s d) were 
calculated, with d=0.2, d=0.5, and d=0.8 considered 
small, moderate, and large, respectively (Cohen, 
1988). The significance level was set at p<.05, and 
the results were expressed as means and standard 
deviations. In addition, 95% confidence intervals 
were calculated for all measurements. Correlations 
matrix between the MDDI total and subscale scores, 
BMI, and WTD were determined using the Spear-
man’s rho (rs) correlation coefficient.
Results
The results of the PCA confirmed the construct 
validity of the translated questionnaire extracting 
three-component matrix (DFS, AI, FI; Table 1). 
Furthermore, the PCA correlation matrix using the 
oblimin revealed that the extracted components in 
Table 1 assessed different dimensions (Table 2). 
Finally, the results of the internal consistency indi-
cated that sampling adequacy (KMO index) for the 
MDDI was .721, and Bartlett’s test of sphericity 
was significant at p<.001. Cronbach’s αs for total 
MDDI, DFS, AI, and FI were .72, .78, .67, and .77, 
respectively.
The results from the CFA indicated that the 
model passed the local minimum for Amos with a 
chi-square of 92.029 and degrees of freedom of 62 
with a probability of <.05. Furthermore, the exami-
nation indicated a good fit based on the IFI, TLI and 
CFI with .925, .901 and .922, respectively (Figure 
1). However, the RMSEA value was .063 (PCLOSE 
= .209), indicating a reasonable error of approxima-
tion (Figure 1). The CMIN was found to be 92.029 
Table 1. Construct validation of the MDDI using the principal component analysis extraction method combined with the oblimin 
with the Kaiser normalization rotation method
Component Matrix Pattern Matrix Structure Matrix
Questions 1 2 3 1 2 3 1 2 3
DFS 1 0.566 0.821 0.808
DFS 4 0.552 0.747 0.741
DFS 5 0.457 0.688 0.681
DFS 6 0.516 0.642 0.644
DFS 8 0.741 0.720 0.759
AI 2 0.587 0.686 0.683
AI 3 0.598 0.762 0.779
AI 7 0.671 0.754 0.733
AI 9 0.555 0.675 0.689
FI 10 0.544 0.790 0.783
FI 11 0.605 0.838 0.838
FI 12 0.456 0.702 0.717
FI 13 0.555 0.762 0.739
Note. MDDI = Muscle Dysmorphic Disorder Inventory; DFS = drive for size; AI = appearance intolerance; FI = functional impairment.
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and the CMIN/FD = 1.484. The model correlation 
matrix presented in Figure 1 indicated that all asso-
ciations were above .7, except for the item number 
12 with .65. The factor loading (fixed to 1) showed 
that the indicator variables loaded significantly on 
all factors (Table 3).
The mean MDDI total score for all participants 
was 33.7 (SD = 6.6) and the mean scores for all 
participants on the MD symptomatology were for 
the DFS 15.2 (SD = 3.9), for the FI 10.4 (SD = 3.5), 
and for the AI 8.1 (SD = 2.6). Moreover, compari-
sons between the normal weight and overweight 
participants (Figure 2) showed no significant or 
trivial difference (d=0.1) in the total MDDI score 
(M = .7, SD = 1.2). However, statistical significant 
but small (d≤.4) differences were observed between 
Table 2. Principal component analysis correlation matrix using the oblimin with the Kaiser normalization
Component Component 1 Component 2 Component 3
DFS (Component 1) 1.000 0.105 0.126
FI (Component 2) 0.105 1.000 0.118
AI (Component 3) 0.126 0.118 1.000
Note. DFS = drive for size; AI = appearance intolerance; FI = functional impairment.
Figure 1. Fit model presented with covariances of the 
Norwegian MDDI confirmatory factor analysis. 
Note. df = degrees of freedom; IFI = incremental fit index; TLI = 
Tucker-Lewis index; CFI = comparative fit index; RMSEA = root 
mean square error of approximation; DFS = drive for size; AI = 
appearance intolerance; FI = functional impairment
Estimate S.E. C.R. P
DFS1 ← DFS 1.000
DFS4 ← DFS .809 .131 6.182 ***
DFS8 ← DFS 1.061 .158 6.721 ***
DFS5 ← DFS .811 .150 5.424 ***
DFS6 ← DFS .782 .152 5.157 ***
FI11 ← FI 1.000
FI10 ← FI .832 .131 6.361 ***
FI13 ← FI .834 .123 6.810 ***
FI12 ← FI .647 .123 5.243 ***
AI3 ← AI 1.000
AI7 ← AI 1.372 .299 4.595 ***
AI2 ← AI .978 .219 4.469 ***
AI9 ← AI .945 .211 4.483 ***
Table 3. The confirmatory factor analysis regression weights 
(group number 1 – default model)
Note. S.E. = standard error; C.R. = critical ratio; DFS = drive for 
size; AI = appearance intolerance; FI = functional impairment.
Note. DFS = drive for size; AI = appearance intolerance; FI = 
functional impairment; WTD = weekly training duration; MDDI 
= muscle dysmorphic disorder inventory total score.
Figure 2. Differences between the normal weight and 
overweight participants on the MDDI total score, MDDI 
subscales (DFS, AI, FI) and WTD.
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the groups in DFS (M = 1.6, SD = .7, p<.01), AI (M 
= .8, SD = .5, p<.01), FI (M = 1.4, SD = .6, p<.01), 
and a moderate significant (d=.7) difference was 
observed in WTD (M = 2.1, SD = .7, p<.01).
All the MDDI subscales were significantly 
correlated with the total MDDI score (p<.01). 
Furthermore, WTD was significantly correlated 
with FI (p<.01), and with BMI (p<.01). Finally, BMI 
was significantly correlated with DFS, FI, and AI 
(p<.05; Table 4).
Discussion and conclusion
The examination of the construct validity of the 
Norwegian translated MDDI resulted in extracting 
the three-component matrix (Table 1). The Cron-
bach’s αs calculated for all the MDDI subscales 
were acceptable with a questionable AI (α=.67), 
but very close to being acceptable compared to the 
α=.45 reported in Santarnecchi and Dettore (2012). 
However, the KMO index for the MDDI was close 
to those reported previously, and the Bartlett’s test 
of sphericity was significant (p<.001; Hildebrandt, 
et al., 2004; Santarnecchi & Dettore, 2012), indi-
cating that the PCA results were reliable and the 
data were suitable for reduction from the translated 
MDDI (Tavakol & Dennick, 2011). Furthermore, the 
PCA correlation matrix (Table 2) strengthened the 
construct validity by indicating that the extracted 
component assessed different qualities, and the rela-
tionship between one component and another was 
observed to be weak. 
The examination of the CFA revealed accept-
able values for IFI, TLI and CFI that were higher 
than the threshold of .9 (Bollen, 1989; Bentler, 
1990). The results further indicate a RMSEA value 
(Figure 1) of .063 (PCLOSE = .209) indicating a 
reasonable error of approximation (Browne & 
Cudeck, 1993). Adding to the reported results, the 
CMIN/FD of 1.484, the model correlation matrix, 
the lack of association between the three dimen-
sions, and the significant loading of the items to the 
factors (Table 3) suggest the usability and confirm 
the MDDI Norwegian version. However, since the 
overall fit (CMIN, CIMIN/DF) is “indicative of 
an acceptable fit between the hypothetical model 
and the sample data” (Carmines & McIver, 1981, 
p. 80) with a significant p value, it is suggested 
that the model need further confirmation using a 
larger sample size. Nevertheless, a good fit result 
from the CFA and the construct validity assessment 
results from the PCA strengthen the evidence for 
the MDDI being a reliable measure for MD symp-
tomatology in Norwegian gym-going men.
The MDDI revealed that MD symptomatology 
was present in a sample of Norwegian gym-going 
men, with the mean MDDI total score of 33.7 (SD 
= 6.6) and means for the subscales 15.2 (SD = 3.9), 
10.4 (SD = 3.5) and 8.1 (SD = 2.6) for DFS, FI and 
AI, respectively. Previous research on the Amer-
ican male weightlifters classified as dysmorphic (n 
= 40) revealed higher mean MDDI subscale scores 
for FI 15.49 (SD = 4.37) and AI 13.67 (SD = 5.17), 
but lower for DFS 14.87 (SD = 4.12) compared to 
that observed in the present study (Hildebrandt, et 
al., 2006). Hildebrandt et al. (2006) reported lower 
results in American male weightlifters classified 
as muscle concerned (n = 63) with mean subscale 
scores of 11.31 (SD = 4.80), 9.51 (SD = 4.83), and 
7.06 (SD = 3.73) for DFS, FI and AI, respectively, 
which were more similar to the present study except 
for the DFS subscale. The observed variations in 
mean scores could be a result of different sample 
sizes, where Hildebrandt et al. (2006) divided the 
237 participants into five groups using latent class 
analysis that generated class membership proba-
bilities leaving them with few participants in each 
group. Comparing the presence of MD symptom-
atology in the present study with other studies is 
difficult to make, as means and SDs for MDDI 
subscale scores were not reported (e.g., Murray, 
et al., 2013; Bo, et al., 2014). The current study 
and previous investigations suggest the need to 
develop a valid and reliable cut-off score for the 
total MDDI score and subscale scores based on clin-
ical examinations to allow for the discrimination 
of categorizing a participant as ‘dysmorphic (with 
MD)’ or ‘non-dysmorphic (without MD)’ (Sand-
gren & Lavallee, 2018; Suffolk, et al., 2013; Tod, 
et al., 2016). A recent study utilized a cut-off score 
(threshold value) of >39 for the total MDDI score (M 
Table 4. Relationships between MDDI total score, MDDI subscales (DFS, AI, FI), WTD, and BMI
Note. ** = p<.01; * = p<.05; MDDI = Muscle Dysmorphic Disorder Inventory; DFS = drive for size; AI = appearance intolerance; FI = 
functional impairment; WTD = weekly training duration; BMI = body mass index.
MDDI total DFS FI AI WTD BMI
MDDI total − .723** .635** .519** .161 -.090
DFS − .122 .219* -.022 -.298**
FI − .096 .420** .305*
AI − -.081 .260*
WTD − .317**
BMI −
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= 29.4, SD = 6.3), classifying participants (competi-
tive and non-competitive bodybuilders; n = 145) as 
at risk (25%) or not at risk (75%) of MD (Longob-
ardi, et al., 2017). Although, the proposed cut-off 
score employed was retrieved from a conference 
poster, and the figure has yet to be empirically vali-
dated. Importantly, with validated cut-off scores 
on MD measurements, reporting prevalence across 
different samples (e.g., gym-goers versus profes-
sional bodybuilders), and cross-cultural compari-
sons (e.g., North America versus Scandinavia) will 
be significantly advanced. 
When comparing the BMI of the classi-
fied normal weight and overweight participants 
according to MD symptomatology scores and 
WTD, statistical significant differences (p<.01) in 
DFS (M = 1.6, SD = 0.7, d=.4), AI (M = 0.8, SD = 
0.5, d=.3), FI (M = 1.4, SD = 0.6, d=.4) and WTD 
(M = 2.1, SD = 0.7, d=.7) were detected (Figure 2). 
The normal weight participants scored significantly 
higher on DFS compared to the overweight partici-
pants, but the difference is considered small (d=.4, 
p<.01), and should therefore be interpreted care-
fully. However, the results suggest that overweight 
participants have a large body mass at current, 
hence they may not want to increase their body 
mass any further compared to that of normal weight 
participants who possess a high drive for increasing 
their body mass. Hildebrandt et al. (2006) reported 
higher DFS (M = 11.31, SD = 4.80) among muscle 
concerned weightlifters with a mean normal weight 
BMI compared to lower DFS (M = 5.50, SD = 4.82) 
in fat concerned weightlifters with a mean over-
weight BMI. On the contrary, Hildebrandt et al. 
(2006) reported even higher DFS (M = 14.87, SD = 
4.12) in dysmorphic weightlifters with a mean over-
weight BMI, but were lower than the DFS scores (M 
= 16.09, SD = 4.02) detected in the normal weight 
participants in the present study, providing support 
for that DFS may be higher in normal weight indi-
viduals training at the gym. 
Furthermore, the overweight participants 
scored significantly higher, but the difference was 
considered small (d=≤.4, p<.01), on the FI and AI 
subscales compared to the normal weight partic-
ipants. In addition, the overweight participants 
reported significantly longer WTD compared to the 
normal weight participants, with a moderate (d=.7, 
p<.01) meaningful difference between the groups. 
The results may indicate that overweight partici-
pants experience a greater intolerance towards 
appearance, spend more hours training in the gym, 
and thus are more likely exposed to experiences of 
impairment in social and occupational settings, in 
line with previous research on male weightlifters 
with a mean overweight BMI and meeting criteria 
for MD (Cafri, et al., 2008). Given the limitation of 
BMI not accounting for fat mass and lean muscle 
mass, the results must be interpreted with caution. 
However, it is possible that the overweight partici-
pants in the present study were already muscular, 
and thus their goal might be to, for example, become 
leaner and lose excess body fat (Choi, et al., 2002; 
Pope, et al., 2005; Robert, et al., 2009; Cafri, et 
al., 2006). Martinez-Segura et al. (2014) concluded 
that the risk of developing MD increases with the 
degree of obesity (according to BMI), indicating 
that higher MD symptomatology scores were asso-
ciated with having a large body mass which was in 
line with the present study. Hildebrandt et al. (2006) 
also reported higher DFS, FI, and AI scores among 
dysmorphic weightlifters with a mean overweight 
BMI compared to muscle concerned weightlifters 
with a mean normal weight BMI. Nevertheless, the 
lack of a statistical significant difference (p>.05, 
d=.1) between the MDDI total scores of the normal 
weight (M = 33.3, SD = 7.1) and overweight (M = 
34.0, SD = 6.1) participants in the present study, 
combined with the absence of a cut-off score further 
support that the MDDI subscales could be more 
important than the total score in evaluating pres-
ence of MD (Robert, et al., 2009). 
Significant relationships were detected between 
the measured variables in the current study (Table 
4). As expected, the total MDDI significantly corre-
lated (p<.01) with all the three subscales, providing 
further evidence for the measurement validity. 
WTD was significantly correlated with BMI (rs 
= .317, p<.01), suggesting that gym-going men 
with higher BMIs also spend longer time training, 
perhaps due to the elevated exposure to AI and FI in 
these individuals as indicated in Figure 2. WTD was 
significantly correlated with FI (rs = .420, p<.01), 
which was in line with Hildebrandt et al. (2004) 
who reported that the FI subscale was significantly 
correlated with the time spent lifting weights, and 
others have confirmed the association between MD 
symptomatology and longer training duration and 
exercise dependence (e.g., Soler, et al., 2013; Guidi, 
et al., 2013). Moreover, a significant negative rela-
tionship was detected between BMI and DFS (rs = 
-.298, p<.01) suggesting that higher scores of DFS 
were more present in those with lower BMIs. Signif-
icant relationships between BMI and FI (rs = .305, 
p<.05), and between BMI and AI (rs = .260, p<.05) 
were also observed, suggesting higher scores of 
FI and AI were more present in those with higher 
BMIs. Some support for the results exists where 
Watkins et al. (2008) found that higher BMIs are 
associated with a negative body image and appear-
ance concerns in 188 college men. These significant 
relationships provide further support for that the 
MD symptomatology DFS may be stronger asso-
ciated with the normal weight participants, and 
MD symptomatology FI and AI may be stronger 
associated with the overweight participants, as also 
indicated in Figure 2. Future research is encour-
aged to investigate these relationships further by 
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including participants’ own perceptions of current 
and desired body size, muscle size, and leanness, 
and other measures of, for example, body dissatis-
faction. Such findings may further advance know-
ledge of the relationship between MD and BMI, 
beyond solely treating BMI as a physical charac-
teristic and predictor (Tod, et al., 2016). 
In conclusion, the Norwegian translated MDDI 
was found to be a valid and reliable measure of 
MD symptomatology in Norwegian gym-going 
men, consistent with that of previous validations 
in American and Italian populations. However, 
additional confirmations are needed with a larger 
sample size to strengthen the validity results. MD 
symptomatology was present in the current sample, 
although to what extent the presence is of concern 
has yet to be determined with a need for future 
research to validate cut-off scores for the MDDI 
total and subscale scores. With no cut-off scores, it 
is difficult to make assumptions about prevalence. 
Moreover, the significant differences between the 
two groups according to BMI, and indicated by the 
significant relationships, could suggest that over-
weight gym-going men have the desired body size, 
but spend more hours training to e.g., improve lean-
ness or lose excess body fat, which might expose 
them to higher FI and AI scores. Normal weight 
gym-going men might experience that they do not 
have the desired body size, and thus want to become 
bigger compared to that of overweight gym-going 
men. The current study suggests that classifying 
individuals according to their BMI enables the 
identification of notable statistical differences in 
MD symptomatology related to their current body 
size. As such, practitioners may wish to consider 
the physical characteristics, the WTD, and evaluate 
concerns based more on the MDDI subscale scores 
rather than the global score when evaluating the 
presence of MD in gym-going men in order to assist 
in offering appropriate care and support. 
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